Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 437

Similar articles for PubMed (Select 18664986)

1.

Modifying clinical practices to manage influenza in children effectively.

Glezen WP.

Pediatr Infect Dis J. 2008 Aug;27(8):738-43. doi: 10.1097/INF.0b013e31816d9299. Review.

PMID:
18664986
2.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

3.

Antivirals and influenza: frequency of resistance.

Monto AS.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S110-2. doi: 10.1097/INF.0b013e318168b739.

PMID:
18820569
4.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

5.

[Neuraminidase inhibitors and risk of H5N1 influenza].

Gras-Masse H, Willand N.

Ann Pharm Fr. 2007 Jan;65(1):50-7. Review. French.

PMID:
17299351
6.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
7.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
8.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
9.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
10.

Influenza: evolving strategies in treatment and prevention.

Lynch JP 3rd, Walsh EE.

Semin Respir Crit Care Med. 2007 Apr;28(2):144-58. Review.

PMID:
17458769
11.

Antiviral management of seasonal and pandemic influenza.

Hayden FG, Pavia AT.

J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26.

12.

Antivirals in the management of an influenza pandemic.

Harrod ME, Emery S, Dwyer DE.

Med J Aust. 2006 Nov 20;185(10 Suppl):S58-61. Review.

PMID:
17115954
14.

Antiviral therapy of influenza.

Englund JA.

Semin Pediatr Infect Dis. 2002 Apr;13(2):120-8. Review.

PMID:
12122950
15.

Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.

[No authors listed]

Wkly Epidemiol Rec. 2007 Apr 27;82(17):149-50. English, French. No abstract available.

16.

Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kawashima T, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2009 Apr 1;48(7):996-7. doi: 10.1086/597360. No abstract available.

17.

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NS; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60.

18.

Antiviral therapy and prophylaxis for influenza in children.

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2007 Apr;119(4):852-60. Review.

PMID:
17403862
20.

[Naturally occurring oseltamivir resistance in influenza A].

Madsen L, Nielsen A, Lundgren J.

Ugeskr Laeger. 2010 Aug 9;172(32):2165-7. Danish.

PMID:
20696118
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk